🇺🇸 FDA
Patent

US 9468632

Methods and compositions for targeting cancer stem cells

granted A61KA61K31/136A61K31/337

Quick answer

US patent 9468632 (Methods and compositions for targeting cancer stem cells) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/136, A61K31/337, A61K31/4035, A61K31/404